Annual report pursuant to Section 13 and 15(d)

ACCRUED EXPENSES (Details)

v3.20.4
ACCRUED EXPENSES (Details) - USD ($)
Dec. 31, 2020
Dec. 31, 2019
ACCRUED EXPENSES    
Incentive compensation $ 850,000 $ 395,000
Accounts payable 1,429,000 1,278,000
Clinical study costs 787,000 720,000
Professional fees 221,000 157,000
Insurance   111,000
Other 156,000 3,000
Accounts Payable and Accrued Liabilities, Current, Total $ 3,443,197 $ 2,663,873